Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan

• Asıl Yazarlar: Rasmussen Zeba A. (Yazar), Bari Abdul (Yazar), Qazi Shamim (Yazar), Rehman Gul (Yazar), Azam Iqbal (Yazar), Khan SherBaz (Yazar), Aziz Farida (Yazar), Rafi Sadia (Yazar), Roghani Mehr Taj (Yazar), Iqbal Imran (Yazar), Nagi Abdul Ghaffar (Yazar), Hussain Waqar (Yazar), Bano Nahida (Yazar), van Latum late J.C (Yazar), Khan Mushtaq (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: The World Health Organization, 2005-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

OBJECTIVE: Increasing concern over bacterial resistance to cotrimoxazole, which is recommended by WHO as a first-line drug for treating non-severe pneumonia, led to the suggestion that this might not be optimal therapy. However, changing to alternative antimicrobial agents, such as amoxicillin, is c...